Back to results
US 2017/0000911 A1Published application
Radiotherapeutic particles and suspensions
AssigneeOncoinvent AS
InventorsRoy Hartvig LARSEN, Sara WESTRØM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a particle or pharmaceutical composition comprising one, more particles or a suspension of same or different particles comprising a degradable compound and an alpha emitting radionuclide and/or a radionuclide generating alpha emitting daughter. The particles are beneficial for use in the treatment of cancer.
Claims17
A therapeutic particle comprising:
- a degradable compound comprising CaCO3;
- and
- an alpha emitting 224Ra radionuclide;
- and
- daughter radionuclides of the alpha emitting 224Ra radionuclide, wherein the daughter radionuclides are 220Rn, 216Po, and 212Pb.
2 more elements
(canceled)
(canceled)
A method of treating cancer in a human in need thereof, comprising administering to the human one or more therapeutic particles, wherein the one or more particles comprise:
- a degradable compound comprising CaCO3;
- and
- an alpha emitting 224Ra radionuclide;
- and
- daughter radionuclides of the alpha emitting 224Ra radionuclide, wherein the daughter radionuclides are 220Rn, 216Po, and 212Pb.
2 more elements
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.